Insider Transactions in Q3 2022 at Adverum Biotechnologies, Inc. (ADVM)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2022
|
Richard Beckman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,272
-9.86%
|
$4,272
$1.07 P/Share
|
|
Sep 19
2022
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
6,058
-11.23%
|
$6,058
$1.07 P/Share
|
|
Sep 19
2022
|
Peter Soparkar CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
13,305
-4.64%
|
$13,305
$1.07 P/Share
|
|
Sep 19
2022
|
Brigit Riley Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,266
-5.77%
|
$7,266
$1.07 P/Share
|
|
Sep 19
2022
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
SELL
Open market or private sale
|
Direct |
41,082
-5.35%
|
$41,082
$1.07 P/Share
|
|
Sep 14
2022
|
Richard Beckman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+41.67%
|
-
|
|
Sep 14
2022
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
33,333
+38.2%
|
-
|